The implications of the HLA-B*51 allele in the development of Behcet disease are still yet to be fully understood, while the involvement of the HLA-B*18:01 variant in antitumor immune response needs much more research and comprehension and HLA-B*35 alleles have no yet determined correlations. Here, HLA-B is linked to Behcet disease.